Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.

Leukemia - 1 Sept 2021

van der Werf Inge, Wojtuszkiewicz Anna, Yao Huilan, Sciarrillo Rocco, Meggendorfer Manja, Hutter Stephan, Walter Wencke, Janssen Jeroen, Kern Wolfgang, Haferlach Claudia, Haferlach Torsten, Jansen Gerrit, Kaspers Gertjan J L, Groen Richard, Ossenkoppele Gert, Cloos Jacqueline

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Antineoplastic Combined Chemotherapy Protocols
Share to fms-Like Tyrosine Kinase 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Phosphoproteins

Share to RNA Splicing Factors

Share to Tandem Repeat Sequences

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 34002025
DOI: 10.1038/s41375-021-01273-7
PMCID: PMC8410582

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.PMID 34002025Read ↗

Targeting FLT3 Mutations in Acute Myeloid LeukemiaSemantic proximity Read ↗

Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments.Semantic proximity Read ↗

FLT3 inhibition in acute myeloid leukaemia.Semantic proximity Read ↗

FLT3 Inhibitors for Treating Acute Myeloid Leukemia.Semantic proximity Read ↗

Role of Biomarkers in FLT3 AMLSemantic proximity Read ↗

Advances in clinical studies of FLT3 inhibitors in acute myeloid leukemia.Semantic proximity Read ↗

FLT3-targeted treatment for acute myeloid leukemia.Semantic proximity Read ↗

Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemiaSemantic proximity Read ↗

FLT3-ITD in acute promyelocytic leukemia: Clinical distinct profile but still controversial prognosisSemantic proximity Read ↗

FLT3 inhibitors: clinical potential in acute myeloid leukemiaSemantic proximity Read ↗

[Advancesin FLT3 inhibitors for acute myeloid leukemia].Semantic proximity Read ↗

Strategies targeting FLT3 beyond the kinase inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.